XpresSpa opened its first XpresCheck service at Terminal 4 at John F. Kennedy International Airport (JFK) to provide COVID-19 screening and testing for terminal employees, airline employees and airport workers.
The new XpresCheck, currently a pilot program, can screen up to 500 employees daily at its modular site in the T4 Arrivals Hall that features nine separate testing rooms and provides the ability to conduct both COVID-19 as well as antibody testing.
These services will be available to all airport employees, including airline employees, contractors and workers, concessionaires and their employees, TSA officers, and U.S. Customs and Border Protection agents. All insurance plans are accepted outside of network and all information will remain private and HIPAA compliant.
“The Port Authority is pleased to open the nation’s first COVID-19 and antibody testing facility for employees at JFK International Airport with JFTIAT and XpresSpa,” says Kevin O’Toole, Chairman of the Port Authority of New York and New Jersey (PANYNJ). “The agency will continue to enhance safety at its facilities by piloting the new technologies, programs, and policies needed to manage the impact of the coronavirus outbreak.”
JFKIAT, the operator of T4, said the launch of XpresCheck is one of many steps it has taken to protect travelers and better serve workers.
“We have always looked for ways to better serve our employees, passengers, and front-line airport workers at Terminal 4,” says Roel Huinink, president and CEO of JFKIAT. “We are very pleased to partner with XpresSpa and the Port Authority to launch the first air terminal testing site in the U.S.”
